SCHEMBL26101752

SCHEMBL26101752

CNc1cc(Nc2cccc(-c3ccc(C=O)cn3)c2OC)nn2c(C(=O)NC(C)C)cnc12

nearest known ligand 0.53

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ TYK2 P29597 20/20 0.53
▸ PDE4D Q08499 11/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30392058 1.00 TYK2 (0.53) TYK2PDE4D
SCHEMBL26100815 0.91 TYK2 (0.51) TYK2PDE4D
SCHEMBL31218652 0.90 TYK2 (0.54) TYK2PDE4D
SCHEMBL30392249 0.87 TYK2 (0.51) TYK2PDE4D
SCHEMBL26101682 0.87 TYK2 (0.51) TYK2PDE4D
SCHEMBL26102149 0.86 TYK2 (0.55) TYK2PDE4D
SCHEMBL30392588 0.84 TYK2 (0.49) TYK2PDE4D
SCHEMBL26101963 0.84 TYK2 (0.49) TYK2PDE4D
SCHEMBL30392568 0.81 TYK2 (0.36) TYK2PDE4D
SCHEMBL26100444 0.81 TYK2 (0.36) TYK2PDE4D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023076161-A1 TYK2 DEGRADERS AND USES THEREOF KYMERA THERAPEUTICS, INC. (US) 2023-05-04 — — WO disclosed
WO-2023076161-A1 TYK2 DEGRADERS AND USES THEREOF KYMERA THERAPEUTICS, INC. (US) 2023-05-04 — — WO disclosed
Send feedback